A Fatal Case of Native Valve Endocarditis with Multiple Embolic Phenomena and Invasive Methicillin-Resistant Staphylococcus aureus Bacteremia: A Case Report from the Maldives
Abstract
:1. Introduction
2. Materials and Methods
2.1. Clinical and Laboratory Data
2.2. Literature Review of Cases with Native Valve IE with MRSA in IVDU
3. Case Description
4. Discussion
4.1. MRSA
4.2. Methicillin-Resistant and Other Virulence Factors
4.3. MRSA as the Causative Agent Was an Unexpected Finding
4.4. This Case Demonstrates the Threat of MRSA
IE Diagnosis of the Present Case
4.5. The Maldives Situation
4.6. IVDU and Other Predisposing Factors
Comparison with Other Reported Cases
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Erdem, H.; Tetik, A.; Arun, O.; Besirbellioglu, B.A.; Coskun, O.; Eyigun, C.P. War and infection in the pre-antibiotic era: The Third Ottoman Army in 1915. Scand. J. Infect. Dis. 2011, 43, 690–695. [Google Scholar] [CrossRef] [PubMed]
- Mathers, C.D.; Boerma, T.; Fat, D.M. Global and regional causes of death. Br. Med Bull. 2009, 92, 7–32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Watanakunakorn, C.; Burkert, T. Infective Endocarditis at a Large Community Teaching Hospital, 1980–1990. A review of 210 episodes. Medicine 1993, 72, 90–102. [Google Scholar] [CrossRef]
- Baddour, L.M.; Wilson, W.R.; Bayer, A.S.; Fowler, V.G., Jr.; Tleyjeh, I.M.; Rybak, M.J.; Barsic, B.; Lockhart, P.B.; Gewitz, M.H.; Levison, M.E.; et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015, 132, 1435–1486. [Google Scholar] [CrossRef] [PubMed]
- Wang, A.; Fosbol, E.L. Current recommendations and uncertainties for surgical treatment of infective endocarditis: A comparison of American and European cardiovascular guidelines. Eur. Heart J. 2022, 43, 1617–1625. [Google Scholar] [CrossRef]
- Weinstein, L. Life-threatening complications of infective endocarditis and their management. Arch. Intern. Med. 1986, 146, 953–957. [Google Scholar] [CrossRef]
- Ibtisam, K.; El Bekkaoui, M.; Skiker, I.; Bentata, Y.; Ismaili, N.; Elouafi, N. Vascular Complications of Infective Endocarditis: Diagnosis and Management. Cureus 2021, 13, e14678. [Google Scholar] [CrossRef]
- Mitaka, H.; Gomez, T.; Perlman, D.C. Scleritis and Endophthalmitis Due to Streptococcus pyogenes Infective Endocarditis. Am. J. Med. 2020, 133, e15–e16. [Google Scholar] [CrossRef]
- Contrepois, A. Towards a history of infective endocarditis. Med. Hist. 1996, 40, 25–54. [Google Scholar] [CrossRef] [Green Version]
- Silverman, M.E.; Upshaw, C.B., Jr. Extracardiac manifestations of infective endocarditis and their historical descriptions. Am. J. Cardiol. 2007, 100, 1802–1807. [Google Scholar] [CrossRef]
- Angsutararux, T.; Angkasekwinai, N. Cumulative incidence and mortality of infective endocarditis in Siriraj hospital-Thailand: A 10-year retrospective study. BMC Infect. Dis. 2019, 19, 1062. [Google Scholar] [CrossRef] [Green Version]
- Ambrosioni, J.; Hernandez-Meneses, M.; Tellez, A.; Pericas, J.; Falces, C.; Tolosana, J.M.; Vidal, B.; Almela, M.; Quintana, E.; Llopis, J.; et al. The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century. Curr. Infect. Dis. Rep. 2017, 19, 21. [Google Scholar] [CrossRef]
- Bea, C.; Vela, S.; García-Blas, S.; Perez-Rivera, J.-A.; Díez-Villanueva, P.; de Gracia, A.I.; Fuertes, E.; Oltra, M.R.; Ferrer, A.; Belmonte, A.; et al. Infective Endocarditis in the Elderly: Challenges and Strategies. J. Cardiovasc. Dev. Dis. 2022, 9, 192. [Google Scholar] [CrossRef] [PubMed]
- Hubers, S.A.; DeSimone, D.C.; Gersh, B.J.; Anavekar, N.S. Infective Endocarditis: A Contemporary Review. Mayo. Clin. Proc. 2020, 95, 982–997. [Google Scholar] [CrossRef] [PubMed]
- Ostovar, R.; Schroeter, F.; Erb, M.; Kuehnel, R.-U.; Hartrumpf, M.; Albes, J.M. Endocarditis: Who Is Particularly at Risk and Why? Ten Years Analysis of Risk Factors for In-hospital Mortality in Infective Endocarditis. Thorac. Cardiovasc. Surg. 2022, 70, 1748950. [Google Scholar] [CrossRef]
- Liesenborghs, L.; Meyers, S.; Vanassche, T.; Verhamme, P. Coagulation: At the heart of infective endocarditis. J. Thromb. Haemost. 2020, 18, 995–1008. [Google Scholar] [CrossRef] [PubMed]
- Thiene, G.; Basso, C. Pathology and pathogenesis of infective endocarditis in native heart valves. Cardiovasc. Pathol. 2006, 15, 256–263. [Google Scholar] [CrossRef]
- Araujo, I.R.; Ferrari, T.C.; Teixeira-Carvalho, A.; Campi-Azevedo, A.C.; Rodrigues, L.V.; Guimaraes Junior, M.H.; Barros, T.L.S.; Gelape, C.L.; Sousa, G.R.; Nunes, M.C.P. Cytokine Signature in Infective Endocarditis. PLoS ONE 2015, 10, e0133631. [Google Scholar] [CrossRef]
- Yuan, X.-C.; Liu, M.; Hu, J.; Zeng, X.; Zhou, A.-Y.; Chen, L. Diagnosis of infective endocarditis using echocardiography. Medicine 2019, 98, e17141. [Google Scholar] [CrossRef]
- Rajani, R.; Klein, J.L. Infective endocarditis: A contemporary update. Clin. Med. 2020, 20, 31–35. [Google Scholar] [CrossRef]
- Tasneem, U.; Mehmood, K.; Majid, M.; Ullah, S.R.; Andleeb, S. Methicillin resistant Staphylococcus aureus: A brief review of virulence and resistance. J. Pak. Med. Assoc. 2022, 72, 509–515. [Google Scholar] [CrossRef] [PubMed]
- Enright, M.C.; Robinson, D.A.; Randle, G.; Feil, E.J.; Grundmann, H.; Spratt, B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA 2002, 99, 7687–7692. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Otto, M. MRSA virulence and spread. Cell Microbiol. 2012, 14, 1513–1521. [Google Scholar] [CrossRef] [Green Version]
- Boyle-Vavra, S.; Daum, R.S. Community-acquired methicillin-resistant Staphylococcus aureus: The role of Panton-Valentine leukocidin. Lab Investig. 2007, 87, 3–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Millar, B.C.; Prendergast, B.D.; Moore, J.E. Community-associated MRSA (CA-MRSA): An emerging pathogen in infective endocarditis. J. Antimicrob. Chemother. 2008, 61, 1–7. [Google Scholar] [CrossRef]
- Maharath, A.; Ahmed, M.S. Bacterial Etiology of Bloodstream Infections and Antimicrobial Resistance Patterns from a Tertiary Care Hospital in Male, Maldives. Int. J. Microbiol. 2021, 2021, 3088202. [Google Scholar] [CrossRef]
- Liesman, R.M.; Pritt, B.S.; Maleszewski, J.J.; Patel, R. Laboratory Diagnosis of Infective Endocarditis. J. Clin. Microbiol. 2017, 55, 2599–2608. [Google Scholar] [CrossRef] [Green Version]
- Hilmy, A.I.; Dey, R.K.; Imad, H.A.; Yoosuf, A.A.; Nazeem, A.; Latheef, A.A. Coronavirus disease 2019 and dengue: Two case reports. J. Med. Case Rep. 2021, 15, 171. [Google Scholar] [CrossRef]
- Korhonen, E.M.; Huhtamo, E.; Smura, T.; Kallio-Kokko, H.; Raassina, M.; Vapalahti, O. Zika virus infection in a traveller returning from the Maldives, June 2015. Eurosurveillance 2016, 21, 30107. [Google Scholar] [CrossRef] [Green Version]
- Imad, H.A.; Phadungsombat, J.; Nakayama, E.E.; Suzuki, K.; Ibrahim, A.M.; Afaa, A.; Azeema, A.; Nazfa, A.; Ahmed, A.; Saeed, A.; et al. Clinical Features of Acute Chikungunya Virus Infection in Children and Adults during an Outbreak in the Maldives. Am. J. Trop. Med. Hyg. 2021, 105, 946–954. [Google Scholar] [CrossRef]
- Imad, H.A.; Tanyaratsrisakul, S.; Piyaphanee, W.; Wattanagoon, Y. Skin lesion from Maldives: Classic but forgotten. Travel Med. Infect. Dis. 2017, 17, 74–75. [Google Scholar] [CrossRef] [PubMed]
- Imad, H.A.; Ali, A.A.; Nahuza, M.; Gurung, R.; Ubaid, A.; Maeesha, A.; Didi, S.A.; Dey, R.K.; Hilmy, A.I.; Hareera, A.; et al. Acalculous Cholecystitis in a Young Adult with Scrub Typhus: A Case Report and Epidemiology of Scrub Typhus in the Maldives. Trop. Med. Infect. Dis. 2021, 6, 208. [Google Scholar] [CrossRef] [PubMed]
- Fallati, L.; Castiglioni, S.; Galli, P.; Riva, F.; Gracia-Lor, E.; Gonzalez-Marino, I.; Rousis, N.I.; Shifah, M.; Messa, M.C.; Strepparava, M.G.; et al. Use of legal and illegal substances in Male (Republic of Maldives) assessed by wastewater analysis. Sci. Total. Environ. 2020, 698, 134207. [Google Scholar] [CrossRef]
- Sanaiha, Y.; Lyons, R.; Benharash, P. Infective endocarditis in intravenous drug users. Trends Cardiovasc. Med. 2020, 30, 491–497. [Google Scholar] [CrossRef] [PubMed]
- Del Nogal, G.P.; Bakhati, B.; Ronen, J.A.; Fernandez, A.G. Double Valve Infective Endocarditis Complicated by Systemic Arterial Embolization. Cureus 2021, 13, 19119. [Google Scholar] [CrossRef] [PubMed]
- Khan, A.; Ehtesham, M.; Asif, H.; Riasat, M.; Alsheikhly, K. Successful Debulking of Tricuspid Valve Vegetation Using Suction Filtration and Veno-Venous Bypass. Cureus 2022, 14, 22741. [Google Scholar] [CrossRef]
Day of Illness (Days) | Day 4 † | Day 5 | Day 6 | Day 7 | Day 8 | Day 9 | Day 10 | Day 12 |
---|---|---|---|---|---|---|---|---|
Hospitalization ‡ (Days) | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | |
Leukocytes (5000–10,000/µL) | 13,700 | 21,000 | 21,600 | 20,800 | 18,500 | 26,000 | 25,000 | 48,100 |
Neutrophils (40–60%) | 79.1 | 68.0 | 82.8 | 76.7 | 74.8 | 77.8 | 77.7 | 78.7 |
Lymphocytes (12.2–47.1%) | 3.4 | 14.0 | 6.3 | 12.6 | 16.1 | 11.0 | 12.8 | 7.4 |
Eosinophils (0.0–4.4%) | 0.9 | 0 | 0.2 | 0 | 0 | 0.1 | 0.3 | 0.1 |
Basophils (0.0–0.7%) | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Monocytes (4.4–12.3%) | 16.1 | 17 | 6.4 | 6.3 | 5.4 | 3.9 | 3.9 | 4.6 |
Hemoglobin (11.9–15.4 g/dL) | 13.1 | 12.7 | 10.5 | 9.9 | 9.7 | 9.2 | 8.0 | 7.9 |
Hematocrit (36.2–46.3%) | 38.6 | 39.9 | 32.4 | 28.8 | 29.5 | 24.9 | 24.0 | 23.2 |
Platelets (151,000–304,000/µL) | 23,000 | 4700 | 3500 | 37,300 | 33,400 | 26,600 | 25,000 | 29,000 |
Creatinine (0.7–1.2 mg/dL) | 2.67 | 3.13 | 1.95 | 1.26 | 1.21 | 1.09 | 1.19 | 1.07 |
Urea (19.0–44.1 mg/dL) | 209.0 | 258.9 | 222.5 | 192.6 | 175.4 | 158.3 | 145.5 | 115.5 |
Sodium (136–145 mmol/L) | 138 | 142 | 150 | 157 | 153 | 151 | 152 | 148 |
Potassium (3.5–5.1 mmol/L) | 3.6 | 4.0 | 3.5 | 3.3 | 4.9 | 4.1 | 4.0 | 4.2 |
Total bilirubin (0.2–1.2 mg/dL) | 3.6 | 2.1 | 1.4 | 0.8 | 1.0 | 1.3 | 1.3 | |
Direct bilirubin (0.0–0.5 mg/dL) | 2.3 | 1.4 | 0.9 | 0.3 | 0.4 | 0.8 | 0.9 | |
Albumin (35–5.2 g/dL) | 2.6 | 2.1 | 2.2 | 2.2 | 2.1 | 2.0 | 1.9 | |
Protein (6.4–8.3 g/dL) | 6.0 | 5.0 | 5.1 | 5.7 | 5.7 | 5.6 | 6.2 | |
Aspartate aminotransferase (5.0–34.0 IU/L) | 104 | 124 | 63 | 38 | 26 | 45 | 85 | |
Alanine aminotransferase (0.0–55.0 IU/L) | 49 | 52 | 37 | 31 | 25 | 36 | 71 | |
Alkaline phosphatase (40.0–150.0 IU/L) | 78 | 58 | 69 | 61 | 79 | 94 | 223 | |
INR (2.0–3.0) | 1.2 | 1.3 | 1.1 | 1.1 | 1.3 | |||
APPT (24.6–38.8 s) | 37.6 | 41.7 | 38.2 | 38.9 | 42.6 | |||
PT (11.1–13.1 s) | 14.6 | 15.8 | 13.0 | 13.7 | 16.5 | |||
CRP (0.0–0.5 mg/dL) | 45.5 | 43.4 | 46.5 | 39.0 | 30.7 | 25.3 | 26.8 | 29.2 |
CK (30–200 IU/L) | 382 | 476 | ||||||
CKMB (0.0–24.0 IU/L) | 25 | 51 | ||||||
LDH (140–280 IU/L) | 681 | |||||||
Troponin I (0.0–0.3 ng/mL) | 3.6 | |||||||
Lactate (4.5–19.8 mg/dL) | 69 | |||||||
Hepatitis B surface Ag | Positive | |||||||
Anti-hepatitis B surface Ab | Positive | |||||||
Anti-hepatitis C Ab | Negative | |||||||
RPR | Non-reactive | |||||||
Anti-HIV Ag/Ab | Negative | |||||||
SARS-CoV-2 RT-PCR | Negative | |||||||
Blood culture | Positive | Positive |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shafeeq, A.; Imad, H.A.; Azhad, A.; Shareef, M.; Najmy, M.S.; Siraj, M.M.; Sunil, M.; Rafeeu, R.; Moosa, A.S.; Shaheed, A.; et al. A Fatal Case of Native Valve Endocarditis with Multiple Embolic Phenomena and Invasive Methicillin-Resistant Staphylococcus aureus Bacteremia: A Case Report from the Maldives. Trop. Med. Infect. Dis. 2023, 8, 53. https://doi.org/10.3390/tropicalmed8010053
Shafeeq A, Imad HA, Azhad A, Shareef M, Najmy MS, Siraj MM, Sunil M, Rafeeu R, Moosa AS, Shaheed A, et al. A Fatal Case of Native Valve Endocarditis with Multiple Embolic Phenomena and Invasive Methicillin-Resistant Staphylococcus aureus Bacteremia: A Case Report from the Maldives. Tropical Medicine and Infectious Disease. 2023; 8(1):53. https://doi.org/10.3390/tropicalmed8010053
Chicago/Turabian StyleShafeeq, Ali, Hisham Ahmed Imad, Ahmed Azhad, Migdhaadh Shareef, Mohamed Shaneez Najmy, Mohamed Mausool Siraj, Mohamed Sunil, Rimsha Rafeeu, Aishath Sofa Moosa, Ahmed Shaheed, and et al. 2023. "A Fatal Case of Native Valve Endocarditis with Multiple Embolic Phenomena and Invasive Methicillin-Resistant Staphylococcus aureus Bacteremia: A Case Report from the Maldives" Tropical Medicine and Infectious Disease 8, no. 1: 53. https://doi.org/10.3390/tropicalmed8010053
APA StyleShafeeq, A., Imad, H. A., Azhad, A., Shareef, M., Najmy, M. S., Siraj, M. M., Sunil, M., Rafeeu, R., Moosa, A. S., Shaheed, A., Ngamprasertchai, T., Matsee, W., Aung, P. L., Nguitragool, W., & Shioda, T. (2023). A Fatal Case of Native Valve Endocarditis with Multiple Embolic Phenomena and Invasive Methicillin-Resistant Staphylococcus aureus Bacteremia: A Case Report from the Maldives. Tropical Medicine and Infectious Disease, 8(1), 53. https://doi.org/10.3390/tropicalmed8010053